255 related articles for article (PubMed ID: 35872180)
1. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
Butreddy A
Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
[TBL] [Abstract][Full Text] [Related]
2. Hot-melt extruded hydroxypropyl methylcellulose acetate succinate based amorphous solid dispersions: Impact of polymeric combinations on supersaturation kinetics and dissolution performance.
Butreddy A; Sarabu S; Almutairi M; Ajjarapu S; Kolimi P; Bandari S; Repka MA
Int J Pharm; 2022 Mar; 615():121471. PubMed ID: 35041915
[TBL] [Abstract][Full Text] [Related]
3. Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation.
Bristol AN; Lamm MS; Li Y
Mol Pharm; 2021 Dec; 18(12):4299-4309. PubMed ID: 34738825
[TBL] [Abstract][Full Text] [Related]
4. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
5. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
Bapat P; Paul S; Thakral NK; Tseng YC; Taylor LS
Mol Pharm; 2023 Nov; 20(11):5714-5727. PubMed ID: 37751517
[TBL] [Abstract][Full Text] [Related]
6. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
7. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Konno H; Handa T; Alonzo DE; Taylor LS
Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
[TBL] [Abstract][Full Text] [Related]
9. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
[TBL] [Abstract][Full Text] [Related]
10. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.
Curatolo W; Nightingale JA; Herbig SM
Pharm Res; 2009 Jun; 26(6):1419-31. PubMed ID: 19277850
[TBL] [Abstract][Full Text] [Related]
11. The Amorphous Quercetin/ Hydroxypropylmethylcellulose Acetate Succinate Solid Dispersions Prepared by Co-Precipitation Method to Enhance Quercetin Dissolution.
Wang Y; Fang Y; Zhou F; Liang Q; Deng Y
J Pharm Sci; 2021 Sep; 110(9):3230-3237. PubMed ID: 34004218
[TBL] [Abstract][Full Text] [Related]
12. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
13. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
14. Interplay of Drug-Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions.
Bapat P; Paul S; Tseng YC; Taylor LS
Mol Pharm; 2024 Mar; 21(3):1466-1478. PubMed ID: 38346390
[TBL] [Abstract][Full Text] [Related]
15. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS
Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082
[TBL] [Abstract][Full Text] [Related]
16. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
17. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
Liang Q; Wang YR; Deng YY
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(15):3305-3311. PubMed ID: 31602887
[TBL] [Abstract][Full Text] [Related]
18. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
19. Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.
Monschke M; Wagner KG
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545270
[TBL] [Abstract][Full Text] [Related]
20. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
Solanki NG; Kathawala M; Serajuddin ATM
J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
